Toby Prout

Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance

Christina Guo, Adam Sharp, Bora Gürel et al. · Nature · 2023 · 120 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors

Dionysis Papadatos-Pastos, Wei Yuan, Abhijit Pal et al. · Journal for ImmunoTherapy of Cancer · 2022 · 56 citations · Full text

Medicine, Oncology, Pharmacology +17

Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial

Susana Banerjee, Matthew Krebs, Alastair Greystoke et al. · Nature Medicine · 2025 · 27 citations · Full text

Medicine, Oncology, Pharmacology +17

Discovery and Validation of Methylation Biomarkers for Ulcerative Colitis Associated Neoplasia

Andrew D. Beggs, Jonathan James, Germaine Caldwell et al. · Inflammatory Bowel Diseases · 2018 · 13 citations · Full text

Medicine, Molecular Biology, Oncology +17

A Phase I Trial of CT900, a Novel α-Folate Receptor–Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer

Susana Banerjee, Vasiliki Michalarea, Joo Ern Ang et al. · Clinical Cancer Research · 2022 · 10 citations · Full text

Medicine, Oncology, Pharmacology +16